CVS Health (NYSE:CVS) is scheduled to announce Q4 earnings results on Wednesday, February 12th, before market open.
The consensus EPS Estimate is $1.69 (-21.0% Y/Y) and the consensus Revenue Estimate is $64.01B (+17.6% Y/Y).
Over the last 2 years, CVS has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 6 downward. Revenue estimates have seen 2 upward revisions and 3 downward.